Publications by authors named "Francesca Lawson"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

93,540

Total Likes

2,250

Extended Reach

158,471

Social Features

13
O
Observational study for multiparametric assessment of cardiac congestion in outpatient worsening heart failure (EVOLUTION).
Gad Cotter, Beth Davison, Philip Janiak, Christopher Edwards, Maria Novosadova, Francesca Lawson

Eur J Heart Fail· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy.
James L Januzzi, Javed Butler, Stefano Del Prato, Justin A Ezekowitz, Nasrien E Ibrahim, Francesca Lawson

Am Heart J· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyperglycaemia, ejection fraction and the risk of heart failure or cardiovascular death in patients with type 2 diabetes and a recent acute coronary syndrome.
Sung-Hee Shin, Brian Claggett, Marc A Pfeffer, Hicham Skali, Jiankang Liu, Francesca C Lawson

Eur J Heart Fail· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions.
Abhinav Sharma, Neha J Pagidipati, Robert M Califf, Darren K McGuire, Jennifer B Green, Francesca C Lawson

Circulation· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration.
Jelena P Seferovic, Rhonda Bentley-Lewis, Brian Claggett, Rafael Diaz, Hertzel C Gerstein, Francesca C Lawson

J Diabetes Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Emil Wolsk, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Hertzel C Gerstein, Francesca C Lawson

Circulation· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
Emil Wolsk, Brian Claggett, Marc A Pfeffer, Rafael Diaz, Kenneth Dickstein, Francesca C Lawson

J Am Heart Assoc· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of glucagon-like peptide-1 receptor agonists on heart rate.
Martin Lorenz, Francesca Lawson, David Owens, Denis Raccah, Christine Roy-Duval

Cardiovasc Diabetol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo.
Rhonda Bentley-Lewis, David Aguilar, Matthew C Riddle, Brian Claggett, Rafael Diaz, Francesca Lawson

Am Heart J· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative enoxaparin versus postoperative semuloparin thromboprophylaxis in major abdominal surgery: a randomized controlled trial.
Ajay K Kakkar, Giancarlo Agnelli, William Fisher, Daniel George, Michael R Lassen, Francesca Lawson

Ann Surg· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.
Giancarlo Agnelli, Daniel J George, Ajay K Kakkar, William Fisher, Michael R Lassen, Francesca Lawson

N Engl J Med· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
Sergio Poli-Bigelli, Jose Rodrigues-Pereira, Alexandra D Carides, Guoguang Julie Ma, Krista Eldridge, Francesca Lawson

Cancer· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis